Shanghai Science and Technology Venture Capital (Group) Co., Ltd., established in 2014, is a prominent state-owned venture capital institution based in Shanghai, China. Supervising a registered capital of 1.69 billion yuan and managing directly supervised funds totaling 12 billion yuan, the company plays a crucial role in advancing the development of Shanghai as a global science and technology innovation center. Operated under the oversight of the Shanghai State-owned Assets Supervision and Administration Commission, Shanghai STVC Group aims to foster investment opportunities and support the growth of innovative enterprises within the region.
Noematrix is a technology company that designs and develops intelligent robots. It focuses on artificial intelligence and robotics, integrating multi-dimensional force control strategies and physical common sense into its products. The company aims to provide innovative and reliable solutions to its customers.
Photoacoustic Pharmaceuticals
Series A in 2024
Photoacoustic Pharmaceuticals is an innovative developer of photosensitizers and related products. It is committed to advancing the development of dynamic photoacoustic therapy.
Prospective Innovation Institute
Venture Round in 2024
The Prospective Innovation Institute is a technological achievement transformation service provider dedicated to the development of forward-thinking, disruptive, and unique technologies, as well as the organization of collaborative research on essential technologies.
Baoji Pharmaceutical
Series C in 2024
Baoji Pharmaceutical is a biopharma R&D manufacturer and a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. Baoji Pharmaceutical has established "recombinant human hyaluronidase-based subcutaneous drug delivery technology" and "pharmaceutical equipment required by assisted reproductive" as the core of its two key research and development directions. The company has established three core technology platforms, including a "medicinal enzyme engineering technology center," a "glycoprotein drug engineering technology center," and an "antibody targeting enzyme engineering technology center."
Systech
Series B in 2024
Systech is an electroplating equipment manufacturing company. It manufactures all electroplating and chemical plating equipments.
QH Quartz
Series C in 2024
QH Quartz is a manufacturer specializing in high-quality quartz materials for the semiconductor, photovoltaic, and optical fiber industries. The company focuses on quartz device processing, utilizing premium raw materials to produce high-purity and high-precision quartz and related devices. By providing advanced quartz materials, QH Quartz caters to the needs of industrial users seeking reliable and efficient components for their applications.
Nurunjie Bio
Seed Round in 2023
Nurunjie Bio is a company that creates innovative gene therapy medications. Nurungen is a company that creates innovative gene therapy medications. The company focuses on creating new gene therapy medications by leveraging its cell transdifferentiation and genetic replacement technologies, both of which have independent intellectual property rights. Committed to translating new cell transdifferentiation technology into clinically relevant treatments.
Bitong Semiconductor
Venture Round in 2023
Bitong Semiconductor is a full-service high-tech company that specializes in installing and troubleshooting equipment.
Open Source China
Series B in 2023
Open Source China is a prominent community focused on open source technology, providing a platform for IT developers to discover, utilize, and exchange open source software. The community offers various resources, including open source software libraries, code sharing, discussion forums, and collaborative translation services. It serves as a hub for technical support, allowing users to seek answers to software-related questions and access relevant information. By fostering collaboration and knowledge sharing, Open Source China promotes the development and application of open source technologies among domestic developers, enhancing their ability to innovate and improve these technologies.
VJTBio
Series C in 2023
VJTBio is a biopharmaceutical company specializing in high-end animal protein pharmaceuticals. The firm is dedicated to developing innovative treatments for animal health, with a particular emphasis on reproductive and immune health. By employing genetic recombination techniques, VJTBio focuses on creating biopharmaceuticals that enhance animal reproduction, prevent diseases, and promote overall pet health. In addition to its research and development efforts, the company is involved in the production and sales of these advanced treatments, offering clinical testing and technical services to the biopharmaceutical industry and medical professionals.
Microengine Technology
Seed Round in 2023
Microengine Technology is a company that specializes in offering software development and network promotion services to businesses.
Yuweitek
Series B in 2023
Yuweitek is a company that specializes in the research and development of advanced technologies for automotive safety and connectivity. It focuses on the integration of software and hardware applications related to Beidou satellite positioning, car communication, driving record systems, intelligent video algorithms, and network connection technologies. The company has developed a range of products, including new energy vehicle terminals, satellite positioning vehicle wireless terminals, multimedia car driving recorders, and high-definition cameras, organized into nine product series. In addition to its product offerings, Yuweitek provides various industry platform management software systems to enhance its clients' operational efficiency and safety in car networking and remote monitoring.
Semidrive Technology
Series B in 2022
Nanjing Semidrive Technology Ltd., established in 2018, is a Chinese company specializing in the design and manufacture of core processor chips for automotive applications. It offers a range of products, including the X9 chip for eCockpit systems, the V9 chip for advanced driver assistance systems (ADAS) and autonomous driving, and the G9 chip for vehicle central gateway applications. Semidrive operates with a fabless manufacturing model and has research and development facilities in Nanjing and Beijing, with an additional office in Shenzhen.
Cosemitech
Series C in 2022
Cosemitech (Shanghai) Co., Ltd. is a semiconductor manufacturer based in Shanghai, China, specializing in a range of products including sensor integrated circuits (ICs), power management semiconductors, motor drivers, and automotive system ICs. The company has a strong focus on automotive electronics, with an R&D team that boasts over 12 years of experience in developing integrated circuits specifically for this sector. Cosemitech's products, such as hall switches, gear sensors, LED drivers, and DC to DC switching regulators, are utilized in various applications across Europe and the United States. The company is dedicated to providing innovative solutions in sensor technology, energy management, and industrial control to enhance the functionality and efficiency of modern automotive systems.
Enflame Technology
Series C in 2022
Enflame, also known as Suiyuan Technology, specializes in developing advanced neural network solutions for artificial intelligence applications. The company focuses on creating high-end deep learning chips designed specifically for cloud data centers, optimizing them for AI training platforms. These chips feature a proprietary architecture that delivers significant computational power while ensuring high energy efficiency and low costs. Additionally, they are programmable and compatible with mainstream machine learning frameworks, making them suitable for a wide range of AI training and optimization tasks.
Semitech
Series B in 2022
Semitech is an intelligent manufacturing system supplier focused on providing integrated manufacturing solutions for high-tech industries.
Zun Pai Communication
Seed Round in 2022
Zunpai Communication specializes in the development of high-performance chipsets and solutions for wireless communication, catering to both residential and commercial markets. The company focuses on creating advanced Wi-Fi router chips, including full-range access point system-on-chip (SoC) solutions. Currently, Zunpai is actively working on the development of Wi-Fi 6 technology, while also investing in research for the next generation of Wi-Fi 7 chips. By offering a comprehensive range of smart scene chipsets, Zunpai aims to enhance connectivity and performance in various environments.
Huihe Medical
Series B in 2021
medical
ASR Microelectronics
Series D in 2020
ASR Microelectronics (Shanghai) Co., Ltd. is a semiconductor manufacturer specializing in chips for mobile intelligent communication terminals, navigation, and various consumer electronics. Founded in April 2015 and headquartered in Shanghai's Zhangjiang Hi-Tech Park, the company develops products including smartphones, modems, and integrated system on chips (SoCs). ASR's research and development efforts are supported by teams based in the United States and South Korea, focusing on technological innovation across mobile communications, the Internet of Things, and smart handheld devices. The company boasts comprehensive capabilities in baseband platform development, particularly following its acquisition of Marvell's Mobile Business Unit in 2017, positioning itself as a key player in China's semiconductor landscape. ASR is dedicated to providing efficient technical support and product solutions across multiple communication standards, including 2G, 3G, and 4G technologies.
BociMed
Series A in 2019
BociMed is a company engaged in drug research and development and clinical research. Through the establishment of a standardized service system, it provides high-quality R&D and outsourcing services for drug discovery, preclinical pharmaceutical research and development, clinical I-IV trials and registration.Shanghai Bozhiyan New Drug Technology Co., Ltd. is a high-tech enterprise specializing in drug research and development technical services, Shanghai High-tech Enterprise, Shanghai Credit Creation Enterprise, and Shanghai Small and Medium Enterprise Innovation Undertaking Enterprise. The company started in 2007 and was formerly known as Shanghai Maibo Pharmaceutical Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in raw material sales, drug import registration and regional cooperation development in China. In 2012,
Joymed Technology
Seed Round in 2016
Joymed Technology specializes in the research and development, registration, and manufacturing of medical devices, providing comprehensive solutions tailored for medical equipment businesses. The company focuses on delivering innovative and reliable technology while ensuring high-quality standards in its products. By offering services such as device design, risk management, marketing, and product verification and validation, Joymed Technology enables its clients to develop and launch safe and affordable medical products efficiently. The company aims to become a trusted partner for both domestic and international medical device firms, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through flexible collaboration and optimized design processes, Joymed Technology seeks to accelerate mutual growth with its customers.
roadoor.com
Series A in 2014
Roadoor.com is a provider of online financial information and loan services, dedicated to facilitating connections between financial institutions and borrowers, including individual consumers, small business operators, and enterprises. The platform aims to reduce financing costs and address financing challenges, promoting fair and inclusive financial practices. By streamlining the process for both lenders and borrowers, Roadoor.com enables fast and secure financial transactions, ultimately contributing to a more efficient and accessible financial landscape.
Zhixin Haozheng
Zhixin Haozheng is an inventor of regenerating islet technology. The company focuses on in vitro regeneration of human tissues and organs, with the major pipeline consisting of regenerative islets that can be implanted to cure diabetes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.